Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine
Conditions:   Migraine With Aura;   Migraine Without Aura Interventions:   Drug: Diclofenac Potassium 50Mg/Pkt Oral Pwdr;   Drug: Rimegepant 75 MG Sponsor:   Danish Headache Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 27, 2022 Category: Research Source Type: clinical trials

Acute Neuroendocrine Response to Intravenous Infusion of Diclofenac Sodium
Condition:   Hypopituitarism Interventions:   Drug: Intravenous Infusion of Diclofenac Sodium;   Drug: Intravenous Infusion of Placebo Sponsor:   Azienda Ospedaliera Città della Salute e della Scienza di Torino Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 12, 2022 Category: Research Source Type: clinical trials